Skip to main content
. 2019 May 14;39(5):BSR20190292. doi: 10.1042/BSR20190292

Table 3. Genotype frequencies of RAB5B gene SNPs loci in PCOS and controls.

PCOS (n = 300) Control (n = 300) HWE P OR (95%CI)* P*
rs1045435
GG 255 (85.00%) 285 (95.00%) 0.08 Reference
GC 32 (10.67%) 14 (4.67%) 2.56 (1.28–5.16) 0.006
CC 13 (4.33%) 1 (0.33%) 14.53 (1.97–299.74) 0.001
Additive model 1.12 (0.88–1.42) 0.38
Dominant model 3.35 (1.76–6.46) <0.001
Recessive model 13.54 (1.84–279.24) 0.003
G 542 (90.33%) 584 (97.33%) Reference
C 58 (9.67%) 16 (2.67%) 3.91 (2.16–7.17) <0.001
rs11550558
AA 251 (83.67%) 286 (95.33%) 0.06 Reference
AG 41 (13.67%) 13 (4.33%) 3.59 (1.81–7.24) <0.001
GG 8 (2.67%) 1 (0.33%) 9.12 (1.15–195.71) 0.03
Additive model 1.14 (0.90–1.45) 0.30
Dominant model 3.99 (2.08–7.77) <0.001
Recessive model 8.19 (1.04–175.76) 0.04
A 543 (90.50%) 585 (97.50%) Reference
G 57 (9.50%) 15 (2.50%) 4.09 (2.22–7.64) <0.001
rs34962186
TT 261 (87.00%) 266 (88.67%) 0.06 Reference
TC 34 (11.33%) 31 (10.33%) 1.12 (0.65–1.93) 0.77
CC 5 (1.67%) 3 (1.00%) 1.70 (0.35–9.05) 0.71
Additive model 1.02 (0.80–1.30) 0.92
Dominant model 1.17 (0.70–1.96) 0.62
Recessive model 1.68 (0.35–8.93) 0.72
T 556 (92.67%) 563 (93.83%) Reference
C 44 (7.33%) 37 (6.17%) 1.20 (0.75–1.94) 0.49
rs705700
TT 145 (48.33%) 173 (57.67%) 0.08 Reference
TC 94 (31.33%) 102 (34.00%) 1.10 (0.76–1.60) 0.67
CC 61 (20.33%) 25 (8.33%) 2.91 (1.69–5.04) <0.001
Additive model 1.19 (0.90–1.58) 0.23
Dominant model 1.46 (1.04–2.04) 0.03
Recessive model 2.80 (1.67–4.76) <0.001
T 384 (64.00%) 448 (74.67%) Reference
C 216 (36.00%) 152 (25.33%) 1.66 (1.28–2.14) <0.001
rs58717357
GG 234 (78.00%) 241 (80.33%) 0.14 Reference
GC 61 (20.33%) 53 (17.67%) 1.19 (0.77–1.82) 0.48
CC 5 (1.67%) 6 (2.00%) 0.86 (0.22–3.22) 0.80
Additive model 1.03 (0.80–1.32) 0.86
Dominant model 1.15 (0.76–1.74) 0.55
Recessive model 0.83 (0.22–3.11) 0.76
G 529 (88.17%) 535 (89.17%) Reference
C 71 (11.83%) 65 (10.83%) 1.11 (0.76–1.60) 0.65
rs11171718
GG 231 (77.00%) 274 (91.33%) 0.08 Reference
GA 43 (14.33%) 24 (8.00%) 2.13 (1.22–3.73) 0.007
AA 26 (8.67%) 2 (0.67%) 15.42 (3.51–95.02) <0.001
Additive model 1.19 (0.93–1.52) 0.18
Dominant model 3.15 (1.89–5.26) <0.001
Recessive model 14.14 (3.22–87.00) <0.001
G 505 (84.17%) 572 (95.33%) Reference
A 95 (15.83%) 28 (4.67%) 3.84 (2.43–6.11) <0.001
rs60028217
TT 244 (81.33%) 251 (83.67%) 0.07 Reference
TA 51 (17.00%) 44 (14.67%) 1.19 (0.75–1.90) 0.50
AA 5 (1.67%) 5 (1.67%) 1.03 (0.26–4.15) 0.97
Additive model 1.03 (0.81–1.32) 0.86
Dominant model 1.18 (0.76–1.83) 0.52
Recessive model \ \
T 539 (89.83%) 546 (91.00%) Reference
A 61 (10.17%) 54 (9.00%) 1.14 (0.77–1.71) 0.56
rs772920
CC 185 (61.67%) 177 (59.00%) 0.06 Reference
CG 91 (30.33%) 99 (33.00%) 0.88 (0.61–1.27) 0.53
GG 24 (8.00%) 24 (8.00%) 0.96 (0.50–1.82) 0.89
Additive model 0.96 (0.73–1.25) 0.79
Dominant model 0.90 (0.64–1.26) 0.56
Recessive model \ \
C 461 (76.83%) 453 (75.50%) Reference
G 139 (23.17%) 147 (24.50%) 0.93 (0.71–1.22) 0.64
*

Adjusted for age and BMI. Abbreviations: CI, confidence interval; HWE, Hardy–Weinberg equilibrium; OR, odds ratio; PCOS, Polycystic ovary syndrome.